Customer-centric and science-driven CDMO supporting biopharma companies from R&D to market
A continuum of services to suit every step of your project
Discover our flexible manufacturing solutions for biopharma companies
Expert process development and manufacturing services for a diversity of biotherapeutics.
Flexible development and GMP manufacturing capacities for antibody-drug conjugates.
Integrated services for challenging API from formulation and development to GMP manufacturing.
Customer stories: What they were looking for in a CDMO
We’ve helped our customers develop and manufacture innovative therapies for more than 20 years.
“The team at BrainEver really valued working with GTP. They quickly captured our needs and came back with suitable solutions that fit our tight timelines. Their experience in protein production was, without question, a strong asset in moving from academia research into the inital development phases.”
Hubert Mechain, BrainEver
“At European Vaccine Initiative, we have found GTP to be a very reliable partner. I specifically appreciated the intelligence their team put in the process development, going beyond merely executing our instructions.”
Nicolas Havelange, EVI
“GTP is technically sound and client-oriented. We appreciated the mutual understanding between GTP and Xenothera and how GTP could adapt its offer to our needs.”
Bernard Vanhove, Xenothera
Our expertise spans all stages of therapeutics development from R&D to commercial production
Over 20 Years’ experience
Highly skilled collaborators
Different protein projects
GMP success rate over the past 10 years
Through its network of facilities in Europe, GTP Bioways offers a continuum of services to the biopharma industry.
Depending on you project, our production units will collaborate to offer you the best quality of service and work hand in hand from the start to move your project all the way from discovery lab bench to clinic.
Discover the expertise field of each production unit!
From our blog:Our CDMO experience at your service
The GTP team has developed CHO-based transient transfection services using an optimized in-house protocol for timely production of recombinant proteins. In order to provide timely production of your...
Pichia pastoris has some key advantages that make it a system of choice for the production of certain types of protein. First of all, note that P. pastoris has been reclassified into a new genus,...
GTP's BSO assists technical leaders, assesses risks and is key to the implementation and continued application of a full-fledged biosafety policy. The production of recombinant proteins and...